biotechnology Archives -

Zymergen’s brand new plan to shift from a synthetic biology specialist to a drug discovery player has come

Ginkgo buys Zymergen, but may shed drug discovery business

https://pharmaphorum.com/news/ginkgo-buys-zymergen-but-may-shed-drug-discovery-business/

Just months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion

Billionaire-backed “rejuvenation” start-up Altos Labs launches operations

https://pharmaphorum.com/news/billionaire-backed-rejuvenation-start-up-altos-labs-launches-operations/

JP Morgan has downgraded its valuation of Moderna, saying its $37 billion market cap is way too high

Moderna’s $37B market cap is too high, despite COVID-19 vaccine; analyst

https://pharmaphorum.com/news/modernas-37b-market-cap-is-too-high-despite-covid-19-vaccine-analyst/

Cell and Gene Therapy

Talks from the MHRA, Innovate UK, Plasticell and more

https://pharmaphorum.com/partner-content/talks-from-the-mhra-innovate-uk-plasticell-and-more/

biotechnology